openPR Logo
Press release

RNAi Pesticides Market Growth and Restrain Factors Analysis Report

RNAi Pesticides Market Growth and Restrain Factors Analysis

InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "RNAi Pesticides Market"-, By Application (Insect Pest Control, Weed Management, Disease Management, Resistance Management), By Crop Type (Agricultural Application, Non-Agricultural Application), By Product (Tropical RNAi Pesticide, Seed Embedded RANi, Transgenic RNAi, Others), By Formulation (Liquid Formulation, Granular Formulation, Powder Formulation, Others), Industry Trends, and Global Forecasts, 2024-2031 And Segment Revenue and Forecast To 2031."

The RNAi Pesticides Market is estimated to reach over USD 2.99 billion by 2031, exhibiting a CAGR of 13.8% during the forecast period.

Request for Sample Pages: https://www.insightaceanalytic.com/request-sample/2799

RNA interference (RNAi) pesticides are a type of biopesticide that targets and silence specific genes essential for the survival of pests. This process leverages RNAi, a natural biological mechanism that controls gene expression by inhibiting the translation of specific messenger RNA (mRNA) molecules, thereby preventing the production of proteins necessary for proper cell function. RNAi pesticides are highly precise, designed to disrupt only the genes of pest species while sparing non-target organisms like animals and beneficial insects. These pesticides are being developed to combat agricultural pests, including nematodes, fungi, and insects, which cause significant damage to crops.

There is an ongoing need for RNAi insecticides as agriculture becomes more sophisticated. To meet regulatory standards and customer expectations for sustainable food production, modern farming companies increasingly need to employ advanced strategies for managing insect populations. RNAi pesticides are well-positioned to fulfill these demands by offering efficient pest control strategies that align with global environmental goals. Technological progress, particularly in RNAi delivery methods such as the topical application of double-stranded RNA (dsRNA), is making the technology more feasible and cost-effective, opening up new opportunities for its adoption in various agricultural settings. The RNAi pesticides market is segmented based on crop types, pest targets, application techniques, and geographic areas, with key crop categories including cereals and grains, fruits and vegetables, and specialty crops. The adaptability of RNAi technology allows it to precisely target a wide range of pests, such as nematodes and insects, making it highly appealing for diverse agricultural applications.

List of Prominent Players in the RNAi Pesticides Market:
• Bayer
• Cibus
• DuPont
• RNAiSSANCE AG
• Syngenta Crop Protection AG
• GreenLight Biosciences, Inc.
• TRILLIUM AG
• Innatrix Inc.
• Renaissance BioScience Corp.
• Pebble Labs
• AgroSpheres
• Vestaron Corporation
• Elemental Enzymes Inc.
• Invaio Sciences, Inc

Market Dynamics:
Drivers:
Increasing awareness of the environmental impact of traditional chemical pesticides has fueled demand for eco-friendly alternatives. RNAi pesticides, which offer a targeted approach with minimal impact on non-target organisms and ecosystems, align with global sustainability goals in agriculture. RNAi pesticides provide a highly specific mechanism of action by targeting and silencing genes critical to the survival of pests. This precision minimizes harm to beneficial insects, animals, and humans, making RNAi pesticides an attractive solution for farmers seeking more effective and safer pest management. Ongoing innovations in RNAi delivery methods, such as the topical application of double-stranded RNA (dsRNA), are making RNAi pesticides more practical and cost-effective for large-scale agricultural use. These technological advancements are expanding the commercial viability of RNAi pesticides.

Curious about this latest version of the report? @ https://www.insightaceanalytic.com/enquiry-before-buying/2799

Challenges:
Many farmers and agricultural professionals may not be fully aware of the potential benefits or the mode of action of RNAi pesticides. Overcoming the learning curve and building confidence in this novel technology will require extensive education and outreach efforts. Ensuring the stability of RNAi molecules in the environment is a major technical challenge.

Regional Trends:
North America has the largest market share during the forecast period. There is growing pressure in North America for more sustainable agricultural practices. Consumers and policymakers are increasingly demanding eco-friendly pest control methods that reduce chemical pesticide use. RNAi pesticides, with their precise, environmentally friendly approach, meet these sustainability requirements, making them attractive to North American farmers and agricultural stakeholders. However, Asia-Pacific region has a large agricultural base, and countries like China and India are key players in global food production. There is significant potential for RNAi pesticides as these countries seek innovative solutions to manage crop damage from pests. The need to improve food security and increase crop yields in the face of growing populations is driving interest in advanced pest control technologies, including RNAi pesticides.

Recent Developments:
• In October 2023, Renaissance BioScience Corp., declared the acquisition of its first patent for its ground-breaking yeast-based platform technology intended for RNA bioactive molecule manufacturing and delivery. This patent, which was granted by the China Patent Office, expands the company's vast portfolio of intellectual property to include 50 previously awarded patents and 11 more applications that are presently pending in important international markets with positive results anticipated.
• In March 2022, Bayer, revealed the EPA's commercial registrations for the features necessary to allow its newest corn product, VT4PROTM with RNAi Technology, to be sold in the US. With the addition of VT4PROTM Technology* to Bayer's already robust corn product line, US farmers will have yet another choice for managing pesky above- and below-ground pests.
• In October 2020, AgroSpheres, announced a strategic partnership with Orion Integrated Biosciences, a globally renowned pioneer in the creation and implementation of algorithms for motif fingerprint recognition, or the identification of extremely specific genomic areas. The creation of numerous high-performing solutions in the fields of crop protection, animal health, and biodefense will be made possible by the unique RNAi alliance. Orion will produce cutting-edge, incredibly precise RNAi targets for the crop protection product line of AgroSpheres. Orion will be able to create and develop products for use in biodefense and animal health thanks to AgroSpheres' access to the AgriCell platform.

Get Specific Chapter/Information From The Report: https://www.insightaceanalytic.com/customisation/2799

Segmentation of RNAi Pesticides Market.
Global RNAi Pesticides Market- By Application
• Insect Pest Control
• Weed Management
• Disease Management
• Resistance Management
Global RNAi Pesticides Market - By Crop Type
• Agricultural Application
o Fruits and Vegetables
o Cereals and Grains
o Oilseed and Pulses
o Others
• Non-Agricultural Application
o Turf and Ornamentals
o Forestry
o Residential Pest Control
Global RNAi Pesticides Market - By Product
• Tropical RNAi Pesticide
• Seed Embedded RANi
• Transgenic RNAi
• Others
Global RNAi Pesticides Market - By Formulation
• Liquid Formulation
• Granular Formulation
• Powder Formulation
• Others
Global RNAi Pesticides Market - By Region
North America-
• The US
• Canada
• Mexico
Europe-
• Germany
• The UK
• France
• Italy
• Spain
• Rest of Europe
Asia-Pacific-
• China
• Japan
• India
• South Korea
• Southeast Asia
• Rest of Asia Pacific
Latin America-
• Brazil
• Argentina
• Rest of Latin America
Middle East & Africa-
• GCC Countries
• South Africa
• Rest of the Middle East and Africa

Get more information:
https://www.insightaceanalytic.com/customisation/2799

Contact us:
info@insightaceanalytic.com
InsightAce Analytic Pvt. Ltd.
Visit: http://www.insightaceanalytic.com
Tel : +1 551 226 6109
Asia: +91 79 72967118
Follow Us on LinkedIn @ bit.ly/2tBXsgS
Follow Us On Facebook @ bit.ly/2H9jnDZ
Twitter: https://twitter.com/Insightace

About Us:
InsightAce Analytic is a market research and consulting firm that enables clients to make strategic decisions. Our qualitative and quantitative market intelligence solutions inform the need for market and competitive intelligence to expand businesses. We help clients gain a competitive advantage by identifying untapped markets, exploring new and competing technologies, segmenting potential markets, and repositioning products. Our expertise is in providing syndicated and custom market intelligence reports with an in-depth analysis with key market insights in a timely and cost-effective manner.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release RNAi Pesticides Market Growth and Restrain Factors Analysis Report here

News-ID: 3695909 • Views:

More Releases from InsightAce Analytic Pvt. Ltd

Rice Bran Wax Lubricant Market Size, Share and Trends Analysis Report 2024-2031
Rice Bran Wax Lubricant Market Size, Share and Trends Analysis Report 2024-2031
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Rice Bran Wax Lubricant Market - (By Grade (Food Grade, Industrial Grade, Pharmaceutical Grade), End-use (Automotive, Food and Beverage, Cosmetics and Personal Care, Pharmaceuticals, Chemicals, Others)), Trends, Industry Competition Analysis, Revenue and Forecast To 2031." According to the latest research by InsightAce Analytic, the Global Rice Bran Wax Lubricant Market is valued at US$ 394.6 million
RFCC Catalyst Market Report Latest Trends and Future Opportunities Analysis
RFCC Catalyst Market Report Latest Trends and Future Opportunities Analysis
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global RFCC Catalyst Market - (By Type (Zeolite, Non-Zeolite, Others), By Application (Heavy Gas Oil (HGO), Vacuum Gas Oil (VGO), Residue Feedstock, Others)), Trends, Industry Competition Analysis, Revenue and Forecast To 2031." According to the latest research by InsightAce Analytic, the Global RFCC Catalyst Market is valued at US$ 229.4 million in 2023, and it is expected
Global Real Estate Tokenization Market Current Scenario with Future Aspect Analysis
Global Real Estate Tokenization Market Current Scenario with Future Aspect Analy …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Real Estate Tokenization Market- (By Asset Type (Residential, Commercial, Industrial), By Token Type (Security Tokens, Utility Tokens), By End-User (Investors, Developers)), By Region, Trends, Industry Competition Analysis, Revenue and Forecast To 2031." According to the latest research by InsightAce Analytic, the Global Real Estate Tokenization Market is valued at US$ 2.81 Bn in 2023, and it
Polylactic Acid (PLA) For 3D Printing Market Deep Research Report with Forecast to 2031
Polylactic Acid (PLA) For 3D Printing Market Deep Research Report with Forecast …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Polylactic Acid (PLA) For 3D Printing Market - (By User Type (Hobbyist, Education, Industrial), By Diameter (1.75 MM, 3 MM), By Application (Automotive, Food Packaging, Healthcare, House Hold Items, Others)), Trends, Industry Competition Analysis, Revenue and Forecast To 2031." According to the latest research by InsightAce Analytic, the Global Polylactic Acid (PLA) For 3D Printing Market

All 5 Releases


More Releases for RNA

Global RNA Analysis/Transcriptomics Market Report
The Global RNA Analysis / Transcriptomics Market is projected to expand at a CAGR of 12.5% during the forecast period, to hit USD 8.1 Billion by 2026, according to a recent market report compiled by Global Market Estimates. Due to the rising need for personalized medicines, the demand for RNA Analysis / Transcriptomics is expected to raise the market demand. Browse 156 Market Data Tables and 112 Figures spread through 175
Cancer RNA Expression Market to Reap Excessive Revenues by 2028(By sequencing te …
Worldwide cancer is one of the leading cause of death and effective way of treating it still looks unaccomplished in most parts of the world. The factors which influence the successful treatment of cancer are different depending on the stage of diagnosis, treatment availability and availability of trained healthcare professionals coupled with high economic burden of the disease. The gene expression of cancerous cells varies by cancer type and may
Senior experts from Exicure, Roche, GSK, BioNTech RNA Pharmaceuticals & MiNA The …
With less than 4 weeks until SMi’s 10th annual RNA Therapeutics event (http://www.therapeutics-rna.com/openpr) opens its doors in London, UK next month, registration will soon be closing and delegate places are becoming increasingly limited. Over the course of 2 focused days, attendees will be able to have an exclusive look into key developments in oligonucleotide therapeutics, mRNA technology, delivery mechanisms, and much more, led by industry leaders, scientific pioneers, and academics exploring
RNA Therapy Improves Vision in Child Blindness, hear more about recent developme …
SMi Reports: In light of recent developments in the field of RNA Therapy, SMi’s 10th Annual RNA Therapeutics is set to deliver the latest advancements in February this year. Leber congenital amaurosis (LCA), one of the most common causes of blindness in children, has been the subject of successful RNA therapy as researchers at the University of Pennsylvania recently published new data showing the success of the new therapy which improved
New Confirmed Delegates & Speakers for RNA Therapeutics
SMi are thrilled to welcome Dr. James Hamilton, Vice President, Head of Clinical Development, Arrowhead Pharmaceuticals onto the speaker panel RNA Therapeutics 2018! Dr. James Hamilton is currently responsible for all aspects of clinical trial design, implementation and execution. In this role, Dr. Hamilton managed the ARC-520 and ARC-AAT global programs through Phase 2 of development. Previously, Dr. Hamilton was Medical Director and Head of Corporate Development at Arrowhead. He led
Introducing the 9th Annual RNA Therapeutics 2018
As the requirement for targeted solutions for chronic diseases continues to grow, the interest of pharmaceutical and biotech companies has increasingly focused towards RNA therapeutics, such that by 2020, the RNA Therapeutics Market is predicted to attain $1.2 billion. One of the main challenges in RNA Therapeutics continues to be bridging the gap between in-vivo and in-vitro models, hear key case studies on the development on the latest delivery systems and